These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 15343403)
1. Monitoring of recombinant survival motor neuron protein using fiber-optic surface plasmon resonance. Masson JF; Barnhart M; Battaglia TM; Morris GE; Nieman RA; Young PJ; Lorson CL; Booksh KS Analyst; 2004 Sep; 129(9):855-9. PubMed ID: 15343403 [TBL] [Abstract][Full Text] [Related]
2. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Veldink JH; Kalmijn S; Van der Hout AH; Lemmink HH; Groeneveld GJ; Lummen C; Scheffer H; Wokke JH; Van den Berg LH Neurology; 2005 Sep; 65(6):820-5. PubMed ID: 16093455 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy. Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293 [TBL] [Abstract][Full Text] [Related]
4. Identification of a battery of tests for drug candidate evaluation in the SMNDelta7 neonate model of spinal muscular atrophy. El-Khodor BF; Edgar N; Chen A; Winberg ML; Joyce C; Brunner D; Suárez-Fariñas M; Heyes MP Exp Neurol; 2008 Jul; 212(1):29-43. PubMed ID: 18455159 [TBL] [Abstract][Full Text] [Related]
5. A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels. Wolstencroft EC; Mattis V; Bajer AA; Young PJ; Lorson CL Hum Mol Genet; 2005 May; 14(9):1199-210. PubMed ID: 15790598 [TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test. Su YN; Hung CC; Li H; Lee CN; Cheng WF; Tsao PN; Chang MC; Yu CL; Hsieh WS; Lin WL; Hsu SM Hum Mutat; 2005 May; 25(5):460-7. PubMed ID: 15832310 [TBL] [Abstract][Full Text] [Related]
7. A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy. Vezain M; Saugier-Veber P; Melki J; Toutain A; Bieth E; Husson M; Pedespan JM; Viollet L; Pénisson-Besnier I; Fehrenbach S; Bou J; Frébourg T; Tosi M Eur J Hum Genet; 2007 Oct; 15(10):1054-62. PubMed ID: 17609673 [TBL] [Abstract][Full Text] [Related]
8. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector. Baughan T; Shababi M; Coady TH; Dickson AM; Tullis GE; Lorson CL Mol Ther; 2006 Jul; 14(1):54-62. PubMed ID: 16580882 [TBL] [Abstract][Full Text] [Related]
9. Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy. Jarecki J; Chen X; Bernardino A; Coovert DD; Whitney M; Burghes A; Stack J; Pollok BA Hum Mol Genet; 2005 Jul; 14(14):2003-18. PubMed ID: 15944201 [TBL] [Abstract][Full Text] [Related]
10. Spinal muscular atrophy: from gene to therapy. Wirth B; Brichta L; Hahnen E Semin Pediatr Neurol; 2006 Jun; 13(2):121-31. PubMed ID: 17027862 [TBL] [Abstract][Full Text] [Related]
11. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy. DiMatteo D; Callahan S; Kmiec EB Exp Cell Res; 2008 Feb; 314(4):878-86. PubMed ID: 18078930 [TBL] [Abstract][Full Text] [Related]
12. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells. Angelozzi C; Borgo F; Tiziano FD; Martella A; Neri G; Brahe C J Med Genet; 2008 Jan; 45(1):29-31. PubMed ID: 17932121 [TBL] [Abstract][Full Text] [Related]
13. [Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a reliable method for detection of non-homozygous patients with spinal muscular atrophy]. Long MJ; Song F; Qu YJ; Meng Y; Wang H; Jin YW; Huang SZ Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1259-63. PubMed ID: 18844099 [TBL] [Abstract][Full Text] [Related]
15. Investigation of the role of SMN1 and SMN2 haploinsufficiency as a risk factor for Hirayama's disease: clinical, neurophysiological and genetic characteristics in a Spanish series of 13 patients. Gamez J; Also E; Alias L; Corbera-Bellalta M; Barceló MJ; Centeno M; Raguer N; Gratacós M; Baiget M; Tizzano EF Clin Neurol Neurosurg; 2007 Dec; 109(10):844-8. PubMed ID: 17850955 [TBL] [Abstract][Full Text] [Related]
16. Axonal-SMN (a-SMN), a protein isoform of the survival motor neuron gene, is specifically involved in axonogenesis. Setola V; Terao M; Locatelli D; Bassanini S; Garattini E; Battaglia G Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1959-64. PubMed ID: 17261814 [TBL] [Abstract][Full Text] [Related]
17. LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate. Garbes L; Riessland M; Hölker I; Heller R; Hauke J; Tränkle C; Coras R; Blümcke I; Hahnen E; Wirth B Hum Mol Genet; 2009 Oct; 18(19):3645-58. PubMed ID: 19584083 [TBL] [Abstract][Full Text] [Related]
18. Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy. Zapletalová E; Hedvicáková P; Kozák L; Vondrácek P; Gaillyová R; Maríková T; Kalina Z; Jüttnerová V; Fajkus J; Fajkusová L Neuromuscul Disord; 2007 Jun; 17(6):476-81. PubMed ID: 17475491 [TBL] [Abstract][Full Text] [Related]